180 Life Sciences Corp. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
180 Life Sciences Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2021 to Q3 2024.
  • 180 Life Sciences Corp. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $16.5K, a 97.4% decline year-over-year.
  • 180 Life Sciences Corp. annual Share-based Payment Arrangement, Expense for 2021 was $2.85M, a 9.39% increase from 2020.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $16.5K -$628K -97.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $22.3K -$529K -96% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q3 2023 $645K -$27.5K -4.09% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $551K -$304K -35.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q3 2022 $672K +$237K +54.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $856K +$512K +149% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $596K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q3 2021 $435K Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $344K Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.